Tositumomab is a drug for the treatment of follicular lymphoma. It is an IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells.Tositumomab is applied in a sequential infusion followed by iodine (131I) tositumomab which is the same antibody covalently bound to the radionuclide iodine-131 (131I).
This page contains content from the copyrighted Wikipedia article "Tositumomab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.